Our materials and waste targets
Zero operational waste, including eliminating single use plastics by 2030
25% environmental impact reduction for our products and packaging by 2030
10% waste reduction from supply chain by 2030
 Where safety, quality and regulations permit
How we plan to achieve our targets
Operational waste and single-use plastics
We will achieve zero operational waste through a 20% reduction in the amount of both hazardous and non-hazardous waste we generate, and diverting the material we do generate into circular cycles - for example reuse, recycling and composting.
We also plan to eliminate single-use plastics in our operations by 2030 (excluding those plastics which are critical to product discovery and development, health and safety, and where regulatory obligations allow).
Products and product packaging
We have committed to a 25% environmental impact reduction for product and packaging by 2030. We will achieve this through integrating environmental aspects into the product design process for all new products and selected established products - with the aim of improving the environmental performance of the product throughout its whole life cycle. This includes using recycled card in packaging, e-leaflets for vaccines and more efficient manufacturing methods.
We are working with suppliers to better understand and map our waste in the supply chain. We can then baseline our supply chain waste impact and work with suppliers to develop action plans to help us achieve our target by 2030.
GSK is a member of the Ellen McArthur Foundation to help develop our approach to circularity and to work with other members on collaborative projects for mutual benefit.
Discover how we at GSK are supporting a healthy planet for healthy people
In November 2020, we announced ambitious environmental sustainability goals in both climate and nature